July 25, 2025 - 22:04

In a recent exploration of the biotech landscape, Manoush Zomorodi delves into the conversations that have shaped our understanding of technology's future. By revisiting discussions with leading figures in the field, she highlights the remarkable achievements and missteps of those at the forefront of innovation. These visionaries have not only transformed the way we perceive biotechnology but have also influenced various aspects of our daily lives.
The dialogue emphasizes the duality of progress, showcasing the groundbreaking advancements that have emerged alongside the challenges and ethical dilemmas they present. As these thought leaders share their insights, they paint a picture of a rapidly evolving digital world, characterized by both excitement and caution.
Zomorodi's reflections underscore the importance of understanding the trajectory of biotechnology as it continues to intersect with society. The conversations serve as a reminder that while the future holds immense potential, it also requires careful consideration of the implications of technological advancements.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...